• Contact us
  • Request a quote

    * Required fields:

    Data controller: SPECIPIG.


    Purpose: To manage the sending of electronic newsletters about SPECIPIG products, services and activities.
    Legitimation: Consent of the data subject.
    Recipients: Service providers outside of the European Union that offer appropriate guarantees concerning data protection.
    Rights: Access, rectification and erasure, as well as the other rights listed in the additional information section.
    Additional information: You can find additional detailed information about how SPECIPIG processes your data in the Privacy Policy

      * Required fields:

      Data controller: SPECIPIG.


      Purpose: To manage the sending of electronic newsletters about SPECIPIG products, services and activities.
      Legitimation: Consent of the data subject.
      Recipients: Service providers outside of the European Union that offer appropriate guarantees concerning data protection.
      Rights: Access, rectification and erasure, as well as the other rights listed in the additional information section.
      Additional information: You can find additional detailed information about how SPECIPIG processes your data in the Privacy Policy

      Services

      Specipig is a Contract Research Organization (CRO) focused on the swine model.
      We offer customized services specialized in the pig model, with preclinical support for research centres, hospitals, biomedical, pharmaceutical, biotechnological and medical device companies in all phases of their projects.

      Specipig is a Contract Research Organization (CRO) focused on the swine model. Almost 10 years’ experience with more than 150 projects and customers from more than 14 countries endorse our expertise and capacities.

      Our team is highly qualified in swine management, breeding, health and welfare.
      We are experts on the swine model, with more than 2500 m2 housing facilities, with a breeding centre and more than 300 animal integrated in the same facilities. Enabling our team to acquire expertise and be highly qualified in swine management, breeding, health and welfare.

      Specipig has developed a unique breed of miniature pigs. Facilitating the control of the supply chain and gaining in knowhow of the pig model.

      We are fully GLP certified and entirely compliant with the guidelines issued by ICH, EMA, ISO 10993, FDA and other relevant health authorities.

      A wide team of collaborators on different surgical services and expertise empower Specipig with high competences otherwise difficult to achieve.

      Specipig has a high customization capacity, given its small structure that provides agility and quick response to the demands.

      Biopharma

      Specipig has experience in running drug development in-vivo pig studies to overcome the regulatory requirements. Such as proof of concept, efficacy, pharmacokinetic, multi dose tolerance studies, toxicology studies and skin tolerance trials. All under GLP certification.

      Our aim is to accompany our partners all along the process, from the very beginning of the preclinical phase, overcoming the regulatory requirements.

      Proof of concept

      We run proof of concept preclinical studies, necessary to demonstrate in an in-vivo situation, the real validity of an approach. Frequently these studies are developed in a large animal species, such as the pig model.

      Efficacy studies

      We carry out tests to evaluate the efficacy of test items, adapting the study plan to the requirements of our customers.

      PK / TK

      We run studies of pharmacokinetics and toxicokinetics with the pig model.

      Toxicology

      We study the response of drugs to assess their toxicity and safety in the pig model.

      Proof of concept

      We run proof of concept preclinical studies, necessary to demonstrate in an in-vivo situation, the real validity of an approach. Frequently these studies are developed in a large animal species, such as the pig model.

      Efficacy studies

      We carry out tests to evaluate the efficacy of test items, adapting the study plan to the requirements of our customers.

      PK / TK

      We run studies of pharmacokinetics and toxicokinetics with the pig model.

      Toxicology

      We study the response of drugs to assess their toxicity and safety in the pig model.

      Biopharma

      Specipig has experience in running drug development in-vivo pig studies to overcome the regulatory requirements. Such as proof of concept, efficacy, pharmacokinetic, multi dose tolerance studies, toxicology studies and skin tolerance trials. All under GLP certification.

      Our aim is to accompany our partners all along the process, from the very beginning of the preclinical phase, overcoming the regulatory requirements.

      Medical device

      In-vivo studies to test medical devices, from a prototype level to a regulatory phase, are possible at Specipig. We support medical device companies to establish the best approach to run proof of concept in-vivo studies of new devices or tissues.

      We provide the best experts in each area (human or veterinary medicine surgeons) and open our doors to surgeons provided by the sponsors to support with the implantation or placement procedure.

      We overcome the necessary steps to support a project during the regulatory submission of the in-vivo pig preclinical studies. Running them under GLP certification, when necessary.

      Our aim is to accompany our partners all along the process, from the very beginning of the prototype phase, run verification and usability tests, and to overcome the regulatory requirements, in fully equipped operation rooms and with the support of an in-vivo large animal pig model.

      Proof of concept

      We have the capabilities to test in-vivo preclinical pig model proof of concept studies with surgical instruments, implants, prostheses and other medical material.

      Efficacy studies

      We run studies using the pig model to verify the efficacy of the medical device in an animal model than is near to the characteristics of human patients.

      Biocompatibility

      We test the biocompatibility of materials with in-vivo pig models. In this test, we can determine the safety, security and possible incompatibility of the materials when placed in a living tissue.

      Safety

      All the tests carried out have the guarantee of maximum safety, both for the animals and their handlers.

      ISO 10993

      We run studies to establish local and systemic safety, security and biocompatibility of medical devices following ISO 10993 guidelines.

      Usability tests

      Our studies also allow us to test the usability of medical devices in a real in-vivo situation. With the pig model, that has similar dimension to those of the human patients.

      Proof of concept

      We have the capabilities to test in-vivo preclinical pig model proof of concept studies with surgical instruments, implants, prostheses and other medical material.

      Efficacy studies

      We run studies using the pig model to verify the efficacy of the medical device in an animal model than is near to the characteristics of human patients.

      Biocompatibility

      We test the biocompatibility of materials with in-vivo pig models. In this test, we can determine the safety, security and possible incompatibility of the materials when placed in a living tissue.

      Safety

      All the tests carried out have the guarantee of maximum safety, both for the animals and their handlers.

      ISO 10993

      We run studies to establish local and systemic safety, security and biocompatibility of medical devices following ISO 10993 guidelines.

      Usability tests

      Our studies also allow us to test the usability of medical devices in a real in-vivo situation. With the pig model, that has similar dimension to those of the human patients.

      Medical device

      In-vivo studies to test medical devices, from a prototype level to a regulatory phase, are possible at Specipig. We support medical device companies to establish the best approach to run proof of concept in-vivo studies of new devices or tissues.

      We provide the best experts in each area (human or veterinary medicine surgeons) and open our doors to surgeons provided by the sponsors to support with the implantation or placement procedure.

      We overcome the necessary steps to support a project during the regulatory submission of the in-vivo pig preclinical studies. Running them under GLP certification, when necessary.

      Our aim is to accompany our partners all along the process, from the very beginning of the prototype phase, run verification and usability tests, and to overcome the regulatory requirements, in fully equipped operation rooms and with the support of an in-vivo large animal pig model.